News

Need for a tolerable and efficacious topical Molluscum Contagiosum drug for pediatric use
May 26, 2026

At the recent European Society for Pediatric Dermatology meeting, a peer-reviewed poster was presented ...

Queen City Angels changes name as  deal size, scope shifts
February 4, 2026

Story Highlights Queen City Angels rebranded to QCA Ventures to reflect its national investment scope. The ...

Queen City Angels Rebrands as QCA Ventures™
February 2, 2026

The New Name Reflects Its Evolution into a National Venture Organization Cincinnati, OH — February ...

Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline - Alphyn
December 19, 2025

ANNAPOLIS, Md., Dec. 12, 2025 /PRNewswire/ — Alphyn Biologics, Inc., a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, today ...

Shift Thermal installs first commercial system at the Oak Ridge Civic Center
October 23, 2025

Surrounded by supporters, the Co-Founder and President, Mitch Ishmael and the Shift Thermal team ...

QCA Ventures Chairman Tony Shipley Featured on Invisible Ink podcast
October 20, 2025

QCA Ventures Chairman and Founder Tony Shipley was featured on the season 9 premiere ...

Four Companies from QCA Community Recognized on Inc. Magazine 5000
August 20, 2025

QCA Ventures is proud to see four companies from our community recognized on the ...

QCA Executive Director Scott Jacobs Featured on "Pitch. Fund. Scale" Podcast
July 25, 2025

QCA Executive Director Scott Jacobs was recently featured on TiE SoCal Angels investor Anshuman ...